CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting ...Middle East

PR Newswire - News
CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting
SEATTLE, Nov. 4, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation supporting the Company's pacritinib development program in graft versus host disease (GVHD) at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, being...

Read More Details
Finally We wish PressBee provided you with enough information of ( CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting )

Apple Storegoogle play

Also on site :